Rechercher
×

Appuyez sur ENTER pour rechercher ou sur ESC pour quitter

EVERYTHING YOU NEED TO ACHIEVE THE HIGHEST PRECISION AND ACCURACY IN YOUR CHNS-O PHARMACEUTICAL MATERIALS DETERMINATIONS

30/10/2023

Purity validation and quality control of pharmaceutical materials at every stage of product development are crucial. Discover how VELP supports pharmaceutical laboratories in achieving the highest precision and reliability when determining CHNS-O concentrations in pharmaceutical materials and confirming their purity.
EVERYTHING YOU NEED TO ACHIEVE THE HIGHEST PRECISION AND ACCURACY IN YOUR CHNS-O PHARMACEUTICAL MATERIALS DETERMINATIONS
The chemical characterization of organic compounds plays a crucial role in pharmaceutical companies, both for research and Quality Control. It enables the confirmation of the purity of the materials and maintains tight control over the production, which is a crucial step to ensure that drugs are safe and effective.

In this context, in which predictability and the highest accuracy are critical, elemental analysis stands out as a fast, reliable cost-effective method which can be used to assure the behaviour of pharmaceutical intermediates, excipients and API, to detect unwanted impurities or variations in the composition of the final product.

CHNS-O DETERMINATION IN PHARMACEUTICAL EXCIPIENTS

In this application note, we demonstrate how the VELP EMA 502 Micro Elemental Analyzer enables you to face multiple analytical challenges in pharmaceutical manufacturing successfully and provides you with accurate and fast CHNS-O determinations.

The EMA 502 Micro Elemental Analyzer was successfully used to determine the CHNS-O content of some excipients, such as Corn starch, Lactose, Microcrystalline cellulose, Sodium starch glycolate, Croscarmellose sodium, Crospovidone, Magnesium stearate, Sucrose and Mannitol. The results obtained demonstrate excellent reproducibility and no memory effect was observed when changing the sample, indicating the complete detection of the elements.
 
Read the application note to discover all the details and learn about official methods, analytical procedures, steps of the analysis, and safety precautions.
 
READ THE APPLICATION NOTE

ACHIEVE COMPLIANCE TO 21 CFR PART 11 PROVISIONS

The EMA 502 can be upgraded with the optional 21 CFR Part 11 Package for Pharmaceutical companies and laboratories that require compliance with FDA regulations.

To discover all the details about the  21 CFR Part 11 Package, read this news >>
Siglacom - Internet Partner